荣昌生物(09995.HK)与参天中国订立许可协议

智通财经
Aug 19, 2025
【荣昌生物(09995.HK)与参天中国订立许可协议】智通财经APP讯,荣昌生物(09995.HK)发布公告,于2025年8月18日,公司及参天制药(中国)有限公司(参天中国)订立许可协议,公司将具有自主知识产权的RC28-E注射液(许可产品)有偿许可给参天中国,参天中国将获得在大中华区(即中国、香港、澳门及台湾)及韩国、泰国、越南、新加坡、菲律宾、印度尼西亚及马来西亚(许可范围)的独家开发、生产和商业化权利,而公司将保留RC28-E在上述许可范围以外的全球独家权益。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10